Cita APA

De Benedetti, F., Brunner, H., Baildam, E., Burgos-Vargas, R., Horneff, G., Huppertz, H., . . . Ruperto, N. (2013). PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA). BioMed Central.

Chicago Style Citation

De Benedetti, F., et al. PReS-FINAL-2140: Neutropenia With Tocilizumab (TCZ) Treatment Is Not Associated With Increased Infection Risk in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA). BioMed Central, 2013.

Cita MLA

De Benedetti, F., et al. PReS-FINAL-2140: Neutropenia With Tocilizumab (TCZ) Treatment Is Not Associated With Increased Infection Risk in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA). BioMed Central, 2013.